Virologic Rebound Occurs in ~20 Percent Receiving Nirmatrelvir-Ritonavir

TUESDAY, Nov. 14, 2023 -- For patients receiving nirmatrelvir-ritonavir (N-R) for acute COVID-19, virologic rebound (VR) occurs in about one in five, according to a study published online Nov. 14 in the Annals of Internal Medicine. Gregory E....
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news